Klinikum der Johann Wolfgang Goethe-Universitaet

Frankfurt am Main, Hesse 60590

0 studies enrolling now · 11 studies all time

What they study most

Alzheimer's Disease, Angioedema, Atopic Dermatitis, Brain Edema, Carcinoma, Merkel Cell, Colitis, Ulcerative, Crohn's Disease, Hemophilia A, Metastatic Pancreatic Adenocarcinoma, Moderate to Severe Plaque Psoriasis, Plaque Type Psoriasis, Psoriasis

Studies at this site

• A Study of BAX 888 in Male Adults With Severe Hemophilia A — Completed
• A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease — Completed
• Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction — Stopped early
• Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200) — Completed
• MSB11022 in Moderate to Severe Chronic Plaque Psoriasis — Completed
• A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) — Completed
• Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis — Completed
• Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease — Stopped early
• A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease — Completed
• Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE) — Completed
• An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis — Completed